Renmatix Challenges Patent Dispute Ruling in Delaware, Citing Conflict of Interest

Pennsylvania-based biotechnology company Renmatix Inc. is urging the Delaware Court of Chancery to overturn an arbitral award that favored Finnish company UPM-Kymmene Corp. in an ongoing patent dispute. Renmatix alleges a critical conflict of interest stemming from the Finnish company’s counsel at DLA Piper. For more details, visit the original article.